Company Filing History:
2 out of 1,627 
2 out of 64 
2 out of 101 Years Active: 2015-2018
Title: The Innovative Contributions of Moshe Hoshen
Introduction
Moshe Hoshen is a prominent inventor based in Jerusalem, Israel. He has made significant contributions to the field of cancer research, particularly in the prognosis and treatment of ovarian and gastric cancers. With a total of 4 patents to his name, his work has the potential to impact the lives of many patients.
Latest Patents
One of Hoshen's latest patents is focused on "Compositions and methods for prognosis of ovarian cancer." This invention describes compositions and methods for predicting the prognosis of ovarian cancer subjects. It provides methods for distinguishing between histological subtypes of ovarian cancer tumors and offers compositions for the treatment or prevention of ovarian cancer. Specifically, the invention relates to microRNA molecules associated with these methods and compositions, as well as various nucleic acid molecules related to or derived from them.
Another significant patent is titled "Compositions and methods for prognosis of gastric cancer." This invention outlines compositions and methods for survival prediction in gastric cancer patients following surgical operations. The compositions include microRNA molecules associated with the prognosis of gastric cancer, along with various nucleic acid molecules related to or derived from them.
Career Highlights
Throughout his career, Moshe Hoshen has worked with esteemed institutions such as New York University and Rosetta Genomics Ltd. His research has focused on developing innovative solutions for cancer prognosis, showcasing his dedication to advancing medical science.
Collaborations
Some of his notable coworkers include Eva Hernando and Iman Osman. Their collaborative efforts have contributed to the success of his research and inventions.
Conclusion
Moshe Hoshen's innovative work in cancer research exemplifies the impact that dedicated inventors can have on healthcare. His patents and collaborations highlight the importance of continued research in the fight against cancer.